NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2017$1,000
-50.0%
500
+25.0%
0.00%
Q1 2016$2,000
-66.7%
4000.0%0.00%
Q4 2015$6,000
+50.0%
400
+277.4%
0.00%
Q3 2013$4,0001060.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2023
NameSharesValueWeighting ↓
KLP Enterprises, LLC 6,865,000$3,096,000100.00%
TSP Capital Management Group, LLC 698,674$1,549,0000.79%
Meditor Group Ltd 6,312,700$2,847,0000.61%
Telemetry Investments, L.L.C. 186,200$84,0000.04%
GSA CAPITAL PARTNERS LLP 1,270,500$573,0000.03%
Benchmark Capital Advisors 53,400$24,0000.02%
BOENNING & SCATTERGOOD, INC. 80,150$36,0000.01%
NJ State Employees Deferred Compensation Plan 80,000$36,0000.01%
Centiva Capital, LP 121,720$55,0000.01%
Overbrook Management Corp 48,611$22,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders